Finished
Diffuse Optical Imaging With Indocyanine Green Solution in Imaging Pelvic Lymph Nodes in Patients With Stage II Prostate Cancer Undergoing Surgery
NCT02119858 · City of Hope Medical Center · Updated 12 Aug 2026
- What is being tested
- indocyanine green solution; diffuse optical imaging; robot-assisted laparoscopic surgery; therapeutic lymphadenectomy
- For
- Stage IIA Prostate Cancer; Stage IIB Prostate Cancer
- Kind of study
- Tests a treatment or device on volunteers. Phase 1.
- Who can join
- Ages 18 years to 80 years. About 20 people. The full rules are on the registry page.
- Where
- United States
- When
- Starts or started 22 Aug 2014, ends 7 Feb 2018. Registered 22 April 2014.
- Results
- None posted yet.
In the researchers' words
This clinical trial studies diffuse optical imaging with indocyanine green solution in imaging pelvic lymph nodes in patients with stage II prostate cancer undergoing surgery. Indocyanine green solution is a special dye that can help doctors see the lymph nodes and blood vessels during surgery when visualized under diffuse optical imaging. Indocyanine green solution may improve the ability to detect lymph nodes and may lead to improved accuracy of lymph node removal.
Sites
- City of Hope Medical CenterDuarte, California, United States